NewsRx

Search our medical news database

Dionex Corp.

Chromatography company reports record sales and EPS

Published in Telemedicine Business Week, August 25th, 2004

Dionex Corp. (DNEX) announced record sales and earnings per share (EPS) for its full year and fourth quarter of fiscal 2004.

Sales for the fiscal year ended June 30, 2004, were $258.8 million, an increase of 20%, compared with the $214.9 million reported for the last fiscal year. Excluding the favorable effects of currency fluctuations, sales grew by 12% for the year. Diluted earnings per share for the year were $1.89, an increase of 30% over the $1.45 reported last year. Diluted earnings per share for the year increased 24% compared with the $1.52 reported for fiscal 2003, excluding the write-off of an investment in an unaffiliated entity in fiscal 2003. Cash flow from...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook